| SpectraBase Spectrum ID |
B38Xja6e0J6 |
| Name |
3,4-Methylenedioxyamphetamine PFO |
| Classification |
Methylenedioxyamphetamine designer drug derivative |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
575.057765692 u |
| Formula |
C18H12F15NO3 |
| InChI |
InChI=1S/C18H12F15NO3/c1-7(4-8-2-3-9-10(5-8)37-6-36-9)34-11(35)12(19,20)13(21,22)14(23,24)15(25,26)16(27,28)17(29,30)18(31,32)33/h2-3,5,7H,4,6H2,1H3,(H,34,35) |
| InChIKey |
KAZMQCZVDUFMTM-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
575.274 g/mol |
| Nominal Mass |
575 u |
| Quality |
954 |
| Retention Index |
4103 |
| SMILES |
C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(C(C(C(NC(CC=1C=C2C(=CC1)OCO2)C)=O)(F)F)(F)F)(F)F |
| SPLASH |
splash10-01p9-2900000000-b5def687559dc41d5350 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
N-(1-(1,3-benzodioxol-5-yl)propan-2-yl)-2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctanamide |
| Technique |
GC/MS |
| Wiley ID |
DD2024_002121 |
